Reference: 1. Data on file, Cordis Corporation.
Cramer shares his views on Oracle's re-rating and also discusses the constant battle between growth and value.
Here are the names.
Players include Apple, Google, Microsoft and Samsung.
Samsung's Bioepis unit seeks final approval in Europe of a rheumatoid arthritis drug to compete with Humira.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.